Volume 10 Supplement 2
Canadian Society of Allergy and Clinical Immunology and AllerGen Abstracts 2014
Meeting abstracts
The publication charges for this supplement were funded by the Canadian Society of Allergy and Clinical Immunology and AllerGen.
Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2014. Go to conference site.
Ottawa, ON, Canada23-26 October 2014
Page 1 of 2
-
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A1
-
Epinephrine auto injector administration by parents or patients for anaphylaxis during supervised oral food challenges and assessment of confidence
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A2 -
C-CARE: comparing three years of anaphylaxis in children treated at the Montreal Children’s Hospital
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A3 -
Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A5 -
Raisin allergy in an 8 year old patient
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A6 -
Omalizumab is effective in the treatment of difficult-to-treat chronic spontaneous urticaria
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A8 -
Acute generalized exanthematous pustulosis from imatinib
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A9 -
Type-III hereditary angioedema resolved by surgery
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A10 -
Growth factors regulate proteinase activated receptor – 2 (PAR-2) on airway epithelium
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A11 -
Lessons learned from the development of a school age food allergy education program
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A12 -
SCIg vs. IVIg: let’s give patients the choice!
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A13 -
Use of tiotropium bromide in an adolescent with adrenal suppression secondary to inhaled mometasone furoate
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A14 -
The prophylactic use of C1 esterase inhibitor in HAE patients undergoing invasive procedures
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A15 -
Efficacy and safety of MK-7243: a grass allergy sublingual immunotherapy tablet evaluated in Canadian adults and children
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A16 -
The efficacy and safety of the short ragweed sublingual immunotherapy tablet MK-3641 is similar in asthmatic and nonasthmatic subjects treated for allergic rhinitis with/without conjunctivitis
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A17 -
Treatment of angiotensin-converting enzyme inhibitor related angioedema with icatibant
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A18 -
Anti-Ige monoclonal antibody therapy for the treatment of chronic rhinosinusitis: a systematic review
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A19 -
Penicillin allergies: referral and management practices of anesthesiologists
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A20 -
Clinical evaluation of an allergen Challenge TheatreTM
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A21 -
Technical evaluation of an allergen Challenge TheatreTM
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A22 -
Anaphylaxis associated with folic acid: domestic case review
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A23 -
Anti-Ige monoclonal antibody therapy for the treatment of patients with chronic rhinosinusitis: a multi-disciplinary practice review
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A24 -
Food allergy and PPI-responsive esophageal eosinophilia
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A25 -
B cell Semaphorin 4c expression mitigates the airway hyperresponsiveness and acute inflammation which characterize allergic airway disease
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A26 -
The observed incidence of anaphylaxis and serum sickness in patients receiving omalizumab in a tertiary allergy and asthma clinic in Canada
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A28 -
Value of skin testing children with a family history of food allergy before ingestion of suspect food allergens
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A29 -
Severe allergic reaction to diethyltoluamide (DEET) containing insect repellent
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A30 -
Efficacy of short-ragweed sublingual immunotherapy tablet MK-3641 in monosensitized and polysensitized subjects
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A31 -
The effect of the ragweed sublingual immunotherapy tablet MK-3641 on rescue medication use
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A32 -
Magnitude of changes in patient symptom and medication scores in grass allergy immunotherapy trials: dependency on levels of pollen exposure
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A33 -
Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A34 -
Early presentation of clinical hereditary angioedema symptoms in an infant
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A36 -
A pilot study of quality of life, mood, sleepiness and fatigue in patients with primary humoral immunodeficiency transitioning to subcutaneous immunoglobulin therapy
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A37 -
Buckwheat anaphylaxis: a case report
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A38 -
Reconciliation of health records following penicillin allergy testing of hospitalized patients
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A39 -
A case of acquired angioedema associated with Waldenstrom’s macroglobulinemia treated with rituximab
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A41 -
Diagnosis of autoimmune disease in the setting of immunodeficiency
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A42 -
Diagnosing penicillin allergy in the absence of minor determinant mixture
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A43 -
Food allergic teens: education, anaphylaxis and concerns
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A44 -
Self-administration of a novel subcutaneous bradykinin b2 receptor antagonist, icatibant, as an effective treatment option in patients with hereditary angioedema
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A45 -
Trafficking of TNF via recycling endosomes in neutrophils
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A47 -
Retracted Article: A post-hoc qualitative analysis of real time heads-up pollen counting versus traditional microscopy counting in the environmental exposure unit (EEU)
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A48 -
Teenagers and food allergy education: a systematic review
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A49 -
Proteinase-activated receptor-2 (PAR-2) expression on inflammatory cells in severe asthma
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A50 -
Analysis of icatibant for the treatment of laryngeal hereditary angioedema attacks in the FAST-3 study
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A51 -
Tiotropium respimat® add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of TH2 inflammatory status
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A52 -
Deep TCR repertoire sequencing reveals relative change in peanut specific clonotype in subjects undergoing rush oral immunotherapy
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A53 -
Impact of air pollution on physician office visits for common childhood conditions in Ontario, Canada
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A54 -
Tobacco smoke induces changes in IL-1 family in bronchial epithelial cells obtained from asthmatic individuals
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A55 -
Lineage specific role of Ship1 in development of allergic airway inflammation
Citation: Allergy, Asthma & Clinical Immunology 2014 10(Suppl 2):A56
The official journal of CSACI
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 2.6
5-year Journal Impact Factor: 3.5
Source Normalized Impact per Paper (SNIP): 0.904
SCImago Journal Rank (SJR): 0.749
Speed 2024
Submission to first editorial decision (median days): 11
Submission to acceptance (median days): 139
Usage 2024
Downloads: 1,301,911
Altmetric mentions: 649